Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112279754B reveals a mild blue-light photocatalytic route for fluorinated sesquiterpenes, offering cost-effective scaling for pharmaceutical intermediates.
Novel solid acid catalyst method for herbicide intermediate. Reduces wastewater and prevents configuration inversion for reliable supply.
Novel enzymatic route for high-purity S-Allyl-L-Cysteine from GSAC. Reduces oxidation risks and improves yield for pharmaceutical applications.
Patent CN103898178A details a high-yield enzymatic route for chiral piperidine alcohols, offering significant cost and purity advantages for API manufacturing.
Patent CN115043846B details a visible-light catalyzed route for pyrroloindole derivatives, offering scalable manufacturing and cost-effective pharmaceutical intermediate production.
Patent CN113292633B enables catalyst-free visible light hydrazine modification. Offers high purity unnatural amino acids with reduced manufacturing costs and scalable supply chain reliability.
Patent CN108048438B reveals a novel halohydrin dehalogenase mutant for efficient Atorvastatin side chain synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN110343053B details a high-yield, solvent-free synthesis route for N-(2-ethoxyphenyl)-N'-(4-ethylphenyl)-oxalamide, offering significant cost and purity advantages for industrial supply chains.
Patent CN116143621A reveals a green boron salt catalytic method for converting benzamides to esters. This technology offers high purity, metal-free synthesis for reliable pharmaceutical intermediate supply chains.
Patent CN104276951B reveals mild aqueous oxidation for pyruvate esters. Offers high selectivity, reusable catalysts, and supply chain stability for fine chemical manufacturing.
Patent CN107056590B details a safe industrial method for 4,4'-dimethoxytriphenylchloromethane, offering cost reduction and high purity for nucleoside manufacturing.
Patent CN114605272A details a novel Nickel-catalyzed asymmetric hydrogenation route for (R)-Fluoxetine intermediates, offering significant cost reduction and high enantioselectivity for API manufacturing.
Patent CN116574072A details a green visible-light method for 2,5-diaryl furans. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN101781162B reveals a green dehydration route for trifluoromethyl styrene using montmorillonite, offering high purity and reduced equipment corrosion for industrial scale-up.
Novel enzymatic method for high-purity L-tyrosine. Reduces impurities and simplifies supply chain for pharmaceutical intermediate manufacturing globally.
Patent CN113717910B details a novel tri-enzyme system for (S)-citronellol synthesis, offering superior selectivity and scalable production for the global fragrance industry.
Novel Ir-catalyzed visible light method for polysubstituted cyclopropanes. Enhances yield, reduces by-products, ensures scalable API intermediate production.
Novel preparation method for stable phosphine ligands enabling efficient C-N and C-C coupling. Reduces catalyst loading and improves selectivity for pharmaceutical manufacturing.
Patent CN114835660A reveals a metal-free, visible-light mediated method for oxime ether synthesis, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN115975969A discloses high-efficiency transaminase mutants for Sitagliptin synthesis, offering superior conversion rates and stability for cost reduction in API manufacturing.